Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 2, 2013, Pages 138-147

  Singh, Prabhleen ^a,b   Ricksten, Sven Erik ^c   Bragadottir, Gudrun ^c   Redfors, Bengt ^c   Nordquist, Lina ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b O'Brien Kidney Centre for Acute Kidney Injury   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Acute kidney injury; Chronic kidney disease; Glomerular filtration rate; Nitric oxide; Oxygen consumption; Oxygenation; Renal blood flow

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CONTRAST MEDIUM; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LOOP DIURETIC AGENT; TELMISARTAN; VASOPRESSIN;

ACUTE KIDNEY FAILURE; AUTOREGULATION; CARDIOVASCULAR SURGERY; CHRONIC KIDNEY DISEASE; DIALYSIS; DISEASE COURSE; HEMODYNAMICS; HYPOXEMIA; ISCHEMIA; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGENATION; PRIMARY PREVENTION; REGULATORY MECHANISM; RENAL OXYGENATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SEPSIS; VASOCONSTRICTION;

ACUTE KIDNEY INJURY; ANIMALS; HEMODYNAMICS; HUMANS; KIDNEY; OXYGEN CONSUMPTION; RENAL INSUFFICIENCY, CHRONIC;

EID: 84873111777     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12036     Document Type: Review

References (102)

1. Mehta RL, Chertow GM. Acute renal failure definitions and classification: Time for change? J. Am. Soc. Nephrol. 2003; 14: 2178-87.
2. Heringlake M, Knappe M, Vargas Hein O et al. Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol. 2006; 72: 645-54.
3. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann. Intern. Med. 1998; 128: 194-203.
4. Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit. An update and primer for the intensivist. Crit. Care Med. 2010; 38: 261-75.
5. Brady HR, Singer GG. Acute renal failure. Lancet 1995; 346: 1533-40.
6. Charbonney E, Saudan P, Triverio PA, Quinn K, Mentha G, Martin PY. Prognosis of acute kidney injury requiring renal replacement therapy in solid organ transplanted patients. Transpl. Int. 2009; 22: 1058-63.
7. Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 1981; 256: 10.
8. Davis MJ, Hill MA, Kuo L. Local regulation of microvascular perfusion. In: Tuma RF, Duran WN, Ley K (eds). Handbook of Physiology: Microcirculation, 2nd edn. Elsevier, San Diego. 2008; 161-284.
9. Segal SS. Regulation of blood flow in the microcirculation. Microcirculation 2005; 12: 33-45.
10. Cupples WA, Braam B. Assessment of renal autoregulation. Am. J. Physiol. Renal Physiol. 2007; 292: F1105-23.
11. Pittman RN. Regulation of Tissue Oxygenation, 1st edn. Morgan & Claypool Life Science, San Rafael. 2011.
12. Blantz RC, Deng A, Miracle CM, Thomson SC. Regulation of kidney function and metabolism: A question of supply and demand. Trans. Am. Clin. Climatol. Assoc. 2007; 118: 23-43.
13. Evans RG, Gardiner BS, Smith DW, O'Connor PM. Intrarenal oxygenation: Unique challenges and the biophysical basis of homeostasis. Am. J. Physiol. Renal Physiol. 2008; 295: F1259-70.
14. Cohen JJ, Damm KE. Renal metabolism: Relation to renal function. In: Brenner BM, Rector BA (eds). The Kidney, 2nd edn. Saunders, Philadelphia. 1981; 144-258.
15. Epstein FH, Agmon Y, Brezis M. Physiology of renal hypoxia. Ann N Y Acad Sci. 1994; Apr 15; 718: 72-81; discussion 81-2.
16. Mandel LJ. Primary active sodium transport, oxygen consumption, and ATP coupling and regulation. Kidney Int. 1986; 29: 3-9.
17. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am. J. Physiol. 1994; 267: F1059-62.
18. Deng A, Tang T, Singh P et al. Regulation of oxygen utilization by angiotensin II in chronic kidney disease. Kidney Int. 2009; 75: 197-204.
19. Laycock SK, Vogel T, Forfia PR et al. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ. Res. 1998; 82: 1263-71.
20. Borutaite V, Brown GC. Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem. J. 1996; 315: 295-9.
21. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994; 356: 295-8.
22. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994; 345: 50-4.
23. Miloradovic Z, Mihailovic-Stanojevic N, Grujic-Milanovic J et al. Comparative effects of l-arginine and vitamin C pretreatment in SHR with induced postischemic acute renal failure. Gen. Physiol. Biophys. 2009; 28: 105-11.
24. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003; 46: 1153-60.
25. 1 receptors. Kidney Int. 2003; 63: 202-8.
26. Palm F, Onozato M, Welch WJ, Wilcox CS. Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: Effects of tempol and angiotensin blockade. Hypertension 2010; 55: 298-304.
27. Palm F, Connors SG, Mendonca M, Welch WJ, Wilcox CS. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats. Hypertension 2008; 51: 345-51.
28. Schachinger H, Klarhofer M, Linder L, Drewe J, Scheffler K. Angiotensin II decreases the renal MRI blood oxygenation level-dependent signal. Hypertension 2006; 47: 1062-6.
29. Deng A, Miracle CM, Suarez JM et al. Oxygen consumption in the kidney: Effects of nitric oxide synthase isoforms and angiotensin II. Kidney Int. 2005; 68: 723-30.
30. 1 angiotensin II receptors in renal ischemic injury. Am. J. Physiol. 1998; 274: F79-90.
31. Gunaratnam L, Bonventre JV. HIF in kidney disease and development. J. Am. Soc. Nephrol. 2009; 20: 1877-87.
32. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 2009; 24: 97-106.
33. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006; 3: 187-97.
34. Wheaton WW, Chandel NS. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am. J. Physiol. Cell Physiol. 2010; 300: C385-93.
35. Zhang H, Bosch-Marce M, Shimoda LA et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008; 283: 10892-903.
36. Singh P, Blantz RC, Rosenberger C, Gabbai FB, Schoeb TR, Thomson SC. Aberrant tubuloglomerular feedback and HIF-1alpha confer resistance to ischemia after subtotal nephrectomy. J. Am. Soc. Nephrol. 2012; 23: 483-93.
37. Katavetin P, Miyata T, Inagi R et al. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway. J. Am. Soc. Nephrol. 2006; 17: 1405-13.
38. Rosenberger C, Khamaisi M, Abassi Z et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int. 2008; 73: 34-42.
39. Deng A, Arndt MA, Satriano J et al. Renal protection in chronic kidney disease: Hypoxia-inducible factor activation vs angiotensin II blockade. Am. J. Physiol. Renal Physiol. 2010; 299: F1365-73.
40. Lassnigg A, Schmidlin D, Mouhieddine M et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J. Am. Soc. Nephrol. 2004; 15: 1597-605.
41. Kanji HD, Schulze CJ, Hervas-Malo M et al. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J. Cardiothorac. Surg. 2010; 5: 71. doi:10.1186/1749-8090-5-71.
42. Brezis M, Rosen S. Hypoxia of the renal medulla: Its implications for disease. N. Engl. J. Med. 1995; 332: 647-55.
43. Redfors B, Sward K, Sellgren J, Ricksten SE. Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med. 2009; 35: 115-22.
44. Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med. 2005; 31: 79-85.
45. Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol. Scand. 2009; 53: 1052-9.
46. Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE. Acute renal failure is not an 'acute renal success': A clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit. Care Med. 2010; 38: 1695-701.
47. Clark JK, Barker HG. Studies of renal oxygen consumption in man. I. The effect of tubular loading (PAH), water diuresis and osmotic (mannitol) diuresis. J. Clin. Invest. 1951; 30: 745-50.
48. Lassen NA, Munck O, Thaysen JH. Oxygen consumption and sodium reabsorption in the kidney. Acta Physiol. Scand. 1961; 51: 371-84.
49. Molitoris BA, Falk SA, Dahl RH. Ischemia-induced loss of epithelial polarity. Role of the tight junction. J. Clin. Invest. 1989; 84: 1334-9.
50. +-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am. J. Physiol. 1993; 265: F693-7.
51. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005; 289: R913-35.
52. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N. Engl. J. Med. 1996; 334: 1448-60.
53. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J. Am. Soc. Nephrol. 2006; 17: 1503-20.
54. Oostendorp M, de Vries EE, Slenter JM et al. MRI of renal oxygenation and function after normothermic ischemia-reperfusion injury. NMR Biomed. 2010; 24: 194-200.
55. Legrand M, Mik EG, Johannes T, Payen D, Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol. Med. 2008; 14: 502-16.
56. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol. Renal Physiol. 2001; 281: F887-99.
57. Basile DP. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int. 2007; 72: 151-6.
58. Hattori R, Ono Y, Kato M, Komatsu T, Matsukawa Y, Yamamoto T. Direct visualization of cortical peritubular capillary of transplanted human kidney with reperfusion injury using a magnifying endoscopy. Transplantation 2005; 79: 1190-4.
59. Kwon O, Hong SM, Sutton TA, Temm CJ. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 2008; 295: F351-9.
60. Legrand M, Almac E, Mik EG et al. l-NIL prevents renal microvascular hypoxia and increase of renal oxygen consumption after ischemia-reperfusion in rats. Am. J. Physiol. Renal Physiol. 2009; 296: F1109-17.
61. Melin J. Renal ischemia/reperfusion in diabetes. PhD thesis. Uppsala University, Uppsala, Sweden. 2002.
62. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC. Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int. 1997; 52: 985-91.
63. Ries M, Basseau F, Tyndal B et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J. Magn. Reson. Imaging 2003; 17: 104-13.
64. Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 1994; 43: 629-33.
65. Palm F, Hansell P, Ronquist G, Waldenstrom A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 2004; 47: 1223-31.
66. Hu H, Batteux F, Chereau C et al. Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury. J. Pathol. 2011; 225: 265-75.
67. Lopes JA, Jorge S, Resina C et al. Acute renal failure in patients with sepsis. Crit. Care 2007; 11: 411.
68. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294: 813-8.
69. Schrier RW, Wang W. Acute renal failure and sepsis. N. Engl. J. Med. 2004; 351: 159-69.
70. Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006; 69: 1996-2002.
71. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: What do we really know? Crit. Care Med. 2008; 36 (Suppl. iv):S198-203.
72. Bellomo R, Wan L, Langenberg C, Ishikawa K, May CN. Septic acute kidney injury: The glomerular arterioles. Contrib. Nephrol. 2011; 174: 98-107.
73. Lonnemann G. Diabetic nephropathy and heart surgery: Prevention of perioperative acute renal failure. Clin. Res. Cardiol. 2006; 95 (Suppl. 1): I-54-8.
74. Hofmann L, Simon-Zoula S, Nowak A et al. BOLD-MRI for the assessment of renal oxygenation in humans: Acute effect of nephrotoxic xenobiotics. Kidney Int. 2006; 70: 144-50.
75. United States Renal Data System (USRDS). Annual Data Report. USRDS Coordinating Center, Minneapolis. 2011.
76. Menon V, Sarnak MJ. The epidemiology of chronic kidney disease stages 1-4 and cardiovascular disease: A high-risk combination. Am. J. Kidney Dis. 2005; 45: 223-32.
77. Nangaku M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 2006; 17: 17-25.
78. Norman JT, Fine LG. Intrarenal oxygenation in chronic renal failure. Clin. Exp. Pharmacol. Physiol. 2006; 33: 989-96.
79. Heyman SN, Khamaisi M, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am. J. Nephrol. 2008; 28: 998-1006.
80. Kang DH, Kanellis J, Hugo C et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 2002; 13: 806-16.
81. Kang DH, Joly AH, Oh SW et al. Impaired angiogenesis in the remnant kidney model. I. Potential role of vascular endothelial growth factor and thrombospondin-1. J. Am. Soc. Nephrol. 2001; 12: 1434-47.
82. Kitamura H, Shimizu A, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant-kidney model. Exp. Nephrol. 1998; 6: 328-36.
83. Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J. Am. Soc. Nephrol. 2000; 11: 47-56.
84. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press. Res. 1996; 19: 191-5.
85. Choi YJCS, Nguyen V, Nguyen C et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum. Pathol. 2000; 31: 1491-7.
86. Manotham K, Tanaka T, Matsumoto M et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J. Am. Soc. Nephrol. 2004; 15: 1277-88.
87. Harris DC, Chan L, Schrier RW. Remnant kidney hypermetabolism and progression of chronic renal failure. Am. J. Physiol. 1988; 254: F267-76.
88. Nath KA, Croatt AJ, Hostetter TH. Oxygen consumption and oxidant stress in surviving nephrons. Am. J. Physiol. 1990; 258: F1354-62.
89. + transport in the perfused rat kidney. Am. J. Physiol. 1982; 242: F508-13.
90. + reabsorption and other renal functions. Kidney Int. 1986; 29: 32-40.
91. Cohen SD, Kimmel PL. Long-term sequelae of acute kidney injury in the ICU. Curr. Opin. Crit. Care. 2012; 18: 623-8.
92. Ishani A, Nelson D, Clothier B et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch. Intern. Med. 2011; 171: 226-33.
93. Fouad AA, Qureshi HA, Al-Sultan AI, Yacoubi MT, Al-Melhim WN. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology 2010; 85: 158-67.
94. Efrati S, Berman S, Hamad RA et al. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury. Nephrol. Dial. Transplant. 2011; 27: 136-45.
95. Bayati A, Nygren K, Kallskog O, Wolgast M. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol. Scand. 1990; 139: 271-9.
96. Briguori C, Visconti G, Focaccio A et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury. Circulation 2011; 124: 1260-9.
97. Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE. Dopamine increases renal oxygenation: A clinical study in post-cardiac surgery patients. Acta Anaesthesiol. Scand. 2010; 54: 183-90.
98. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann. Intern. Med. 2005; 142: 510-24.
99. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006; 333: 420.
100. Sward K, Valson F, Ricksten SE. Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. Acta Anaesthesiol. Scand. 2001; 45: 536-42.
101. Valsson F, Ricksten SE, Hedner T, Lundin S. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med. 1996; 22: 230-6.
102. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit. Care Med. 2004; 32: 1310-5.